Skip to content

Lyell Immunopharma, Inc.

LYEL Nasdaq SEC CIK 1806952

Follow Lyell Immunopharma Weekly email: filings, results, news

News

2 stories filed under Lyell Immunopharma

Citizens reiterates Lyell Immunopharma stock rating on pipeline progress

Markets 41 d ago 2 sources

Lyell Immunopharma earnings beat by $0.22, revenue fell short of estimates

Earnings 46 d ago 3 sources

Profile

Headquarters: SOUTH SAN FRANCISCO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator